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Background -Sputum analysis provides a non-invasive method of examining the airway secretions of subjects with asthma in order to better understand the inflammatory process. Increased proportions of eosinophils are generally seen in the sputum of subjects with asthma, especially when there is an exacerbation. An ted not to use their bronchodilator or had not been prescribed a bronchodilator before the screening visit. The study was approved by the hospital research committee and all subjects gave written informed consent. was confirmed by analysis of a second sputum sample within 21 days (5-6%, 4-5%, 4-3%, respectively) before enrollment in the study. One subject was reclassified to the non-eosinophilic group because the initial eosinophil count of 5X3% was 1d1% on the second occasion. The selection of .4% eosinophils to define eosinophilic sputum was based on the 95% confidence intervals of 06% to 3-2% about the mean of 1-9% eosinophils in the sputum smears of 14 normal subjects studied by Pin et al." In a subsequent examination of 20 specimens from 10 healthy non-asthmatic subjects using cytospins the mean differential eosinophil count was 0 5% and the 95% confidence interval was 03% to 0Q7%.2 DATA ANALYSIS Group characteristics were expressed as mean (SD) or geometric mean (for PC20). Group means were compared by unpaired t tests for continuous variables and by X2 for categorical variables. PC20 values were logarithmically transformed for analysis. Least squares regression analysis was used to look at the relationship between eosinophil counts, FEV_, and PC20.
Results A sputum differential eosinophil count of > 4% was found in only 18 of the 34 subjects despite the fact that their current symptoms suggested exacerbated asthma (tables 1 and 2). The total and differential cell counts were otherwise similar between these subjects and those with noneosinophilic sputum. Subjects who were able to produce spontaneous sputum (eight eosTumer, Hussack, Sears, Dolovich, Hargmave (20 2%) . Furthermore, the proportion of subjects with a history of respiratory tract infection within two months (50% eosinophilic v 54% non-eosinophilic), who were smokers (17% v 25%), or who were on treatment with inhaled corticosteroid (44% v 31%) was not different between the groups.
Discussion
In the course of recruiting subjects for a clinical trial to investigate the anti-inflammatory properties of asthma medications we selected subjects with mild exacerbations of asthma which appeared to be established and not improving. We expected this clinical presentation to be associated with eosinophilic airways inflammation. To our surprise, almost half (47%) of the first 34 consecutive subjects who met the clinical trial entry criteria did not have sputum eosinophilia. The subjects with noneosinophilic sputum had a trend to less cough, wheeze, and spontaneous sputum production. They had significantly less airways obstruction and there was a trend to fewer bronchodilators and less severe airways hyperresponsiveness than those with eosinophilic sputum. There was no obvious difference in the cause of the exacerbation between the groups. The results raise the possibility that, if the sputum cell counts are reliable, there may be a diversity of causes or a diversity of inflammatory responses in mild, naturally occurring exacerbations of asthma.
The accuracy of the sputum cell counts is suggested by their repeatability. We have shown that differential counts examined on stained smears of sputum (the mean counts of four smears within and between specimens) is highly reproducible."' In the present study we have replaced sputum smears with stained cytospins made from sputum treated with dithiothreitol to disperse the cells.7 The cells are easier to recognise and count on cytospins and repeatability of counts on a single cytospin is better than on a single smear. We therefore believe that cytospin counts are a more accurate reflection of the cells found in sputum. In comparison with the smear method, cytospins from healthy subjects show similar eosinophil counts but higher neutrophil counts." 2 In the present study, subjects with spontaneous sputum had higher differential eosinophil counts than those in whom the sputum had to be induced. This raises the possibility that induced sputum underestimates the proportion of eosinophils. However, early comparison of spontaneous and induced sputum in the same subjects has shown similar differential cell counts.'3 The higher eosinophil counts in spontaneous sputum observed in this study are therefore probably the result of more inflammation and secretions and not a failure of induced sputum to provide representative counts.
The ability of examination of the sputum to represent airway mucosal inflammation has been suggested by the responsiveness and validity of the measurements and the comparison with cell counts in bronchial washings and bronchoalveolar lavage (BAL) fluid. The responsiveness has been shown by increases in the proportion of eosinophils in sputum after allergen inhalation causing dual asthmatic ren w w sponses and heightened methacholine responsiveness,2 and by a decrease in eosinophils after corticosteroid treatment.59 The validity of counts has been shown by differences between healthy subjects and two groups who have airways inflammation of different pathogenesis, specifically asthmatics and smokers with nonobstructive bronchitis.' 11 1214 Early comparison of cell counts in sputum compared with bronchial washings and BAL fluid have shown that the proportion of eosinophils is highest in sputum."5 We therefore believe that sputum cell counts in asthma reflect events in the mucosa of the airways.
Subjects in this study all had asthma defined by physiological criteria. With an established exacerbation of symptoms we expected sputum eosinophilia to be present. Why then did almost half of the subjects not have this feature? One possibility is that the sensitivity of sputum eosinophilia to detect a mild exacerbation of asthma defined by symptoms and reversible airways obstruction is poor. The exacerbation was objectively less severe in the non-eosinophilic group. However, sputum eosinophils increase readily after a mild exacerbation of asthma caused by allergen inhalation23 or by a reduction in inhaled steroid treatment.5 Alternatively, the definition of eosinophilia of > 4% may have been set too high. While the level we selected seemed appropriate," 12 it is possible that counts below 4% could be raised if baseline sputum eosinophil cell counts in the non-exacerbated state were virtually zero. The answer to these questions will require studies involving a comparison of sputum findings with those in bronchial biopsy samples, and the addition of inhaled steroid treatment to both non-eosinophilic and eosinophilic groups of subjects.
Assuming that the methods of examination of sputum cell counts are reliable, the results raise the possibility of different causes of inflammatory responses. We could not identify obvious differences between the groups of subjects in current exposure to allergens, smoking, and use of inhaled corticosteroids or evidence of infection. Perhaps the symptoms in the noneosinophilic group were of non-inflammatory origin. Symptoms are known to be non-specific and might be manifestations of stress, hyperventilation, laryngeal dysfunction or increased exposure to causes of bronchoconstriction not associated with inflammatory cell infiltration.
On the other hand, while there was no significant difference between the groups in sputum total cell count or differential neutrophil counts, the neutrophil counts were increased in certain individual subjects. Increased neutrophils in sputum have been reported in a study of more severe exacerbations of asthma, '6 in BAL fluid in non-asthmatic subjects three hours after exposure to ozone,'7 and in the cartilaginous airways ofthree subjects with sudden onset (less than 1-5 hours) fatal asthma. '8 An increase in neutrophils in bronchial mucus also occurs with infections and asthma exacerbations are commonly associated with viral infection. '9 In future studies the aetiology and types of non-allergic inflammation -for example, infection -need prospective evaluation with objective measurements.
The results of this study illustrate that symptoms of asthma do not necessarily predict eosinophilic airways inflammation in asthma. This should not be a surprise, since accurate assessment of other characteristics of asthma such as airways obstruction,20 variable airways obstruction,2' and airways hyperresponsiveness22 also require direct objective measurements. The results underline the need to measure indices of airways inflammation in asthma and other airways diseases to better understand their causes, clinical effects, and responses to treatment. There is increasing evidence that examination of sputum cell counts is a practical method of measuring airways inflammation in asthma. Sputum measurements in future studies of clinical asthma might also include cellular activation markers2324 and fluid phase constituents such as ECP and albumin.121425
